Synthesis of SMO Inhibitor PF-04449913

Synfacts

doi 10.1055/s-0033-1341076

Full Text

Abstract

Available in

Date

Authors

Unknown

Publisher

Georg Thieme Verlag KG

Related search

Evaluation of the Effects of Formulation, Food, or a Proton-Pump Inhibitor on the Pharmacokinetics of Glasdegib (PF-04449913) in Healthy Volunteers: A Randomized Phase I Study

Cancer Chemotherapy and Pharmacology
Cancer ResearchToxicologyOncologyPharmacology
2018English

Genetic Mutations Predict SMO Inhibitor Response in SHH Medulloblastoma

Cancer Discovery
Oncology
2014English

Synthesis and Biological Evaluation of BODIPY-PF-543

Molecules
Organic ChemistryMolecular MedicineAnalytical ChemistryTheoretical ChemistryPharmaceutical ScienceMedicineDrug DiscoveryChemistryPhysical
2019English

Small-Molecule P21-Activated Kinase Inhibitor PF-3758309 Is a Potent Inhibitor of Oncogenic Signaling and Tumor Growth

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2010English

Met Tyrosine Kinase Inhibitor, PF-2341066, Suppresses Growth and Invasion of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Kje Smo Izgubili »zakaje«?

Metodički obzori/Methodological Horizons
2012Latvian

Biomarker and Pharmacologic Evaluation of the -Secretase Inhibitor PF-03084014 in Breast Cancer Models

Clinical Cancer Research
Cancer ResearchOncology
2012English

Synthesis of a PCSK9 Inhibitor

Synfacts
2018English

Smoothened (SMO); Suppressor of Fused Homolog (SUFU)

Science-Business eXchange
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy